Literature DB >> 22118031

Evaluation of wound healing and antimicrobial potentials of Ixora coccinea root extract.

Nagaraj Selvaraj1, Baskar Lakshmanan, Papiya Mitra Mazumder, Muthukumar Karuppasamy, Simon Santosh Jena, Ashok Kumar Pattnaik.   

Abstract

OBJECTIVE: To evaluate the wound healing and antimicrobial activity of root extracts of Ixora coccinea (I. coccinea).
METHODS: To investigate the wound healing efficacy of root extract of I. coccinea Linn, five groups of animals were divided each containing six animals. Two wound models including incision and excision wound models were used in this study. The parameters studied were tensile strength on incision wound model and in terms of wound contraction for excision wound model were compared with standard Nitrofurazone (NFZ) ointment (0.2% w/w). Six extracts (ethanol, aqueous, petroleum ether, benzene, chloroform and ethyl acetate) of I. coccinea were screened for in vitro growth inhibiting activity against different bacterial strains viz, Staphylococcus aureus, Bacillus pumilius, Enterococcus faecalis, Escherichia coli, Salmonella typhi and Pseudomonas aeruginosa and fungi Candida albicans and Aspergillus niger were compared with the standard drugs ciprofloxacin and chloramphenicol for antibacterial and griseofulvin for antifungal screening. The serial dilution and cup (or) well plate methods were used for the antimicrobial study and MIC was determined.
RESULTS: The ethanolic extract showed significant (P<0.001) wound healing activity when compared to standard drug NFZ with respect to normal control group. Amongst all, ethanolic extract showed highly significant antibacterial activity against all bacterial strains used in this study when compared to standard. The aqueous extract showed moderate significant inhibition against all bacterial strains when compared to standard. All the extracts were shown negligible activity against the fungal strains used in this study.
CONCLUSIONS: The ethanolic root extract of I. coccinea showed pronounced wound healing and antibacterial activity. The probable reason to heal the wound was that the external application of the extract prevented the microbes to invade through the wound thus the protection of wound occurs against the infection of the various organisms.
Copyright © 2011 Hainan Medical College. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22118031     DOI: 10.1016/S1995-7645(11)60226-5

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  5 in total

1.  Ultrasound-assisted Extraction of Ursolic Acid from the Flowers of Ixora coccinia Linn (Rubiaceae) and Antiproliferative Activity of Ursolic Acid and Synthesized Derivatives.

Authors:  Silvana Amadeu Ferreira Alves Monteath; Maria Aparecida M Maciel; Raquel Garcia Vega; Heloisa de Mello; Carollina de Araújo Martins; Andressa Esteves-Souza; Cerli Rocha Gattass; Aurea Echevarria
Journal:  Pharmacogn Mag       Date:  2017-04-18       Impact factor: 1.085

2.  The biomedical potential of genetically modified flax seeds overexpressing the glucosyltransferase gene.

Authors:  Magdalena Czemplik; Anna Kulma; Karolina Bazela; Jan Szopa
Journal:  BMC Complement Altern Med       Date:  2012-12-10       Impact factor: 3.659

Review 3.  Can scientific evidence support using Bangladeshi traditional medicinal plants in the treatment of diarrhoea? A review on seven plants.

Authors:  Helle Wangensteen; Line Klarpås; Mahiuddin Alamgir; Anne B C Samuelsen; Karl E Malterud
Journal:  Nutrients       Date:  2013-05-22       Impact factor: 5.717

4.  Ixora coccinea Enhances Cutaneous Wound Healing by Upregulating the Expression of Collagen and Basic Fibroblast Growth Factor.

Authors:  Aadesh Upadhyay; Pronobesh Chattopadhyay; Danswrang Goyary; Papiya Mitra Mazumder; Vijay Veer
Journal:  ISRN Pharmacol       Date:  2014-01-29

Review 5.  Herbal Drugs from Sudan: Traditional Uses and Phytoconstituents.

Authors:  Mohamed Gamaleldin Elsadig Karar; Nikolai Kuhnert
Journal:  Pharmacogn Rev       Date:  2017 Jul-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.